{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Editing the Genetics of Alzheimer\u2019s","description":"Dr. Ornit Chiba-Falek\u2019s work as an Alzheimer\u2019s researcher sounds almost like science fiction \u2013 but it\u2019s real. At the Duke University School of Medicine, Chiba-Falek and her colleagues are probing the ways that science can essentially turn off the specific DNA sequences that can lead to Alzheimer\u2019s and other forms of dementia. The science is still in its early stages, but Chiba-Falek is optimistic that her work will eventually lead to new targeted therapies for people living with dementia. There may never be a silver bullet cure for every person, but by learning more about the different ways our DNA affects our risk, Chiba-Falek and her team are laying the groundwork for the next generation of treatments. Chiba-Falek joins \u201cElevate Eldercare,\u201d along with former Green House Project intern and current Duke student Meghna Datta, to discuss her work and the present state of Alzheimer\u2019s treatment, including the controversial new drug aducanumab.   Learn about Chiba-Falek\u2019s work at Duke: https:\/\/neurology.duke.edu\/research\/lab-and-translational-research\/ornit-chiba-falek-phd Explore Chiba-Falek\u2019s gene therapy startup, CLAIRIgene: http:\/\/clairigene.com\/   Show notes\/call to action: Learn more about The Green House Project: www.thegreenhouseproject.org ","author_name":"Elevate Eldercare","author_url":"https:\/\/www.aginginnovation.org","html":"